The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUC.L Regulatory News (NUC)

  • There is currently no data for NUC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM - amendment

7 Apr 2021 15:15

RNS Number : 7218U
Nucleus Financial Group PLC
07 April 2021
 

This announcement replaces the announcement released on 7 April 2021 at 7.00 am under RNS No 5517U and the heading 'Posting of Annual Report and Financial Statements and Notice of Annual General Meeting'. The date of the AGM has been changed from Wednesday 27 May 2021 to the correct day, Thursday 27 May 2021. All other details remain unchanged.

 

 

 

7 April 2021

 

Nucleus Financial Group plc

(the "Company")

Posting of Annual Report and Financial Statements and Notice of Annual General Meeting

Nucleus Financial Group plc announces that the Company's Annual General Meeting ("AGM") will be held at 9am on Thursday 27 May 2021 at Nucleus HQ, Greenside, 12 Blenheim Place, Edinburgh, EH7 5JH.

The Annual Report and Financial Statements for the year ended 31 December 2020, together with the Notice of AGM, will be available at https://nucleusfinancial.com/investors on the Company's website and will be posted today to those shareholders who have elected to receive hard copy communications from the Company. Proxy forms will be posted to all shareholders today.

The Company published a Covid-19 statement on 23 March 2020 noting that its highest priority is the health and wellbeing of its stakeholders. This has continued to be the case throughout the Covid-19 crisis, and it is for this reason that all shareholders are requested not to attend the AGM in person and appoint a proxy. Details of the AGM will be available on our website at https://nucleusfinancial.com/investors. Shareholders are encouraged to send any questions that would have been raised at the AGM to IR@nucleusfinancial.com in advance of the AGM and answers to questions will be published on the Company website as soon as practicable. Please refer to the Notice of AGM for further details.

 

Contacts

Nucleus Financial Group plc

David Ferguson, CEO

Tel: +44(0)13 1226 9800

Stuart Geard, CFO

Shore Capital (Nominated Adviser and Broker)

Tel: +44 (0)20 7408 4090

Hugh Morgan

Edward Mansfield

Daniel Bush 

Camarco (Media enquiries)

Tel: +44 (0)20 3757 4994

Jennifer Renwick

Jake Thomas

 

 

Notes to Editors

About Nucleus

Nucleus is a wrap platform provider founded in 2006 by advisers committed to aligning their interests with their clients to alter the balance of power in the industry and put client interests centre stage. Its technology and data-oriented platform has been built in partnership with users and now provides services to more than 1,400 active adviser users from a total user base of some 2,877 advisers from 861 financial advice firms as at 21 March 2021. It is responsible for over £17.8bn of AUA on behalf of more than 101,000 customers.

 

The multi award-winning platform offers a range of custody, trading, payment, reporting, fee-handling, research and integration services across a variety of tax wrappers and more than 6,500 asset choices including cash, OEICs, unit trusts, offshore funds, structured products and listed securities, including ETFs and investment trusts. The platform currently facilitates over 1.1 million customer account transactions on average per month.

 

Nucleus has been awarded CoreData's 'Best medium sized platform' for 2020 (and the last nine years). It has also been awarded a 5-star service rating at the 2019 and 2020 Financial Adviser Awards, the Schroders 'Platform of the Year' award for 2016, 2017 and 2018 (and highly-commended 2020 runner up) and won 'Best Platform' and 'Best Platform Innovation' at the 2018 Money Marketing Awards.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAZDLFBFZLFBBX
Date   Source Headline
21st Sep 20217:30 amRNSSuspension - Nucleus Financial Group plc
7th Sep 20217:00 amRNSStrategic Update and Directorate Change
23rd Aug 202112:28 pmRNSNotice of proposed cancellation of trading on AIM
10th Aug 20213:19 pmRNSForm 8.3 - Nucleus Financial Group PLC
6th Aug 20215:30 pmRNSNucleus Financial Group
6th Aug 20212:28 pmRNSDirector/PDMR Shareholding
6th Aug 20217:30 amRNSDirector changes
6th Aug 20217:00 amRNSOffer wholly unconditional
16th Jul 20217:00 amRNSQ2 2021 AUA update
18th Jun 20218:50 amRNSDirector/PDMR Shareholding
10th Jun 20219:28 amRNSForm 8.3 - Nucleus Financial Group Plc
27th May 202110:08 amRNSResult of AGM
25th May 20212:55 pmRNSUpdate on Offer Timetable and Level of Acceptances
17th May 20215:28 pmRNSDirector/PDMR Shareholding
5th May 20217:00 amRNSOffer unconditional as to acceptances
27th Apr 202110:07 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
23rd Apr 202110:14 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
21st Apr 20218:30 amRNSForm 8.3 - Nucleus Financial Group PLC
20th Apr 20218:57 amRNSForm 8.3 - Nucleus Financial Group PLC
14th Apr 20212:51 pmRNSDirector/PDMR Shareholding
14th Apr 20219:45 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
13th Apr 20212:51 pmRNSForm 8 (DD) - Nucleus Financial Group plc
13th Apr 20212:16 pmRNSDirector/PDMR Shareholding
13th Apr 202112:35 pmRNSPublication and posting of Offer Document
13th Apr 20219:48 amRNSForm 8.3 - [NUCLEUS FINANCIAL GROUP PLC]
13th Apr 20219:45 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
13th Apr 20217:00 amRNSQ1 2021 AUA update
9th Apr 20219:17 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
9th Apr 20218:51 amRNSForm 8.3 - NUCLEUS FINANCIAL GROUP PLC
9th Apr 20217:00 amRNSOffer Document – change of publication date
7th Apr 20213:15 pmRNSNotice of AGM - amendment
7th Apr 20218:55 amRNSForm 8.3 - NUCLEUS FINANCIAL GROUP PLC
7th Apr 20217:00 amRNSNotice of AGM
1st Apr 202110:34 amRNSForm 8.3 - [NUCLEUS FINANCIAL GROUP PLC]
31st Mar 202110:44 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
31st Mar 20218:55 amRNSForm 8.3 - [NUCLEUS FINANCIAL GROUP PLC]
30th Mar 202111:52 amRNSRecommended Cash Offer
29th Mar 20214:21 pmRNSDirector/PDMR Shareholding
25th Mar 20213:58 pmRNSDirector/PDMR Shareholding
25th Mar 20219:38 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
25th Mar 20218:37 amRNSForm 8.3 - Nucleus Financial Group PLC
24th Mar 20219:24 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
23rd Mar 20217:00 amRNSFinal results
19th Mar 20219:34 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
17th Mar 202112:08 pmGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
17th Mar 20218:59 amRNSForm 8.3 - NUCLEUS FINANCIAL GROUP PLC
16th Mar 20218:52 amRNSForm 8.3 - NUCLEUS FINANCIAL GROUP PLC
15th Mar 20214:45 pmRNSForm 8 (DD) - Nucleus Financial Group plc
15th Mar 20214:39 pmRNSDirector/PDMR Shareholding
15th Mar 202111:46 amRNSForm 8.3 - Nucleus Financial Group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.